2025 Guidance Update
RadNet updates guidance levels as follows:
| Imaging Center Segment | ||||||
| Original Guidance Range | Revised Guidance Range After Q1 Results | Revised Guidance Range After Q2 Results | ||||
| Total Net Revenue | $1,825 - $1,875 million | $1,835 - $1,885 million | $1,850 - $1,900 million | |||
| Adjusted EBITDA(1) | $265 - $273 million | $268 - $276 million | $271 - $279 million | |||
| Capital Expenditures(a) | $140 - $150 million | $145 - $155 million | $152 - $162 million | |||
| Cash Interest Expense(b) | $35 - $40 million | $35 - $40 million | $35 - $40 million | |||
| Free Cash Flow (2) | $70 - $80 million | $70 - $80 million | $70 - $80 million | |||
| (a) Net of proceeds from the sale of equipment and New Jersey Imaging Network capital expenditures. | ||||||
| (b) Net of payments from counterparties on interest rate swaps and interest income from our cash balance recorded in Other Income. | ||||||
| Digital Health Segment | ||||
Original Guidance Range | Revised Guidance Range After Q1 Results | Revised Guidance Range After Q2 Results | ||
| Total Net Revenue (inclusive of intersegment revenue) | $80 - $90 million | $80 - $90 million | $80 - $90 million | |
| Adjusted EBITDA(1) Before Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI | $15 - $17 million | $15 - $17 million | $15 - $17 million | |
| Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI | $16 - $18 million | $16 - $18 million | $17 - $19 million | |
| Capital Expenditures | $3 - $5 million | $3 - $5 million | $2 - $4 million | |
| Free Cash Flow(2) Before Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI | $11 - $13 million | $11 - $13 million | $11 - $13 million | |
| Free Cash Flow(2) After Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI | $(5) - $(8) million | $(5) - $(8) million | $(5) - $(8) million | |
Conference Call for Tomorrow
Dr. Howard Berger, President and Chief Executive Officer, and Mark Stolper, Executive Vice President and Chief Financial Officer, will host a conference call to discuss its second quarter 2025 results on Monday, August 11th, 2025 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).
Conference Call Details:
Date: Monday, August 11, 2025
Time: 10:30 a.m. Eastern Time
Dial In-Number: 844-826-3035
International Dial-In Number: 412-317-5195
It is recommended that participants dial in approximately 5 minutes prior to the start of the 10:30 a.m. call. There will also be simultaneous and archived webcasts available at https://viavid.webcasts.com/starthere.jsp?ei=1729070&tp_key=3a3e8702a3 or http://www.radnet.com under the “Investors” menu section and “News Releases” sub-menu of the website. An archived replay of the call will also be available and can be accessed by dialing 844-512-2921 from the U.S., or 412-317-6671 for international callers, and using the passcode 10201853.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.